Tudor Investment Corp
VNDA icon

Tudor Investment Corp’s Vanda Pharmaceuticals VNDA Stock Holding History

Tudor Investment Corp’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$707K Buy
102,255
+13,667
+15% +$105K ﹤0.01% 2602
2025
Q4 		$781K Sell
88,588
-40,048
-31% -$220K ﹤0.01% 2450
2025
Q3 		$642K Sell
128,636
-8,653
-6% -$40.1K ﹤0.01% 2556
2025
Q2 		$648K Buy
137,289
+2,858
+2% +$12.5K ﹤0.01% 2417
2025
Q1 		$617K Buy
134,431
+109,813
+446% +$512K ﹤0.01% 2147
2024
Q4 		$118K Buy
24,618
+9,180
+59% +$44.1K ﹤0.01% 2899
2024
Q3 		$72.4K Buy
+15,438
New +$82.8K ﹤0.01% 2609
2024
Q2 		– Sell
-139,040
Closed -$571K – 2837
2024
Q1 		$571K Buy
139,040
+102,628
+282% +$411K ﹤0.01% 1593
2023
Q4 		$154K Buy
+36,412
New +$147K ﹤0.01% 2229
2023
Q1 		– Sell
-10,740
Closed -$79K – 2991
2022
Q4 		$79K Buy
+10,740
New +$105K ﹤0.01% 2235
2022
Q3 		– Sell
-66,114
Closed -$721K – 2745
2022
Q2 		$721K Sell
66,114
-32,242
-33% -$334K 0.02% 1081
2022
Q1 		$1.11M Buy
98,356
+30,846
+46% +$405K 0.03% 853
2021
Q4 		$1.06M Buy
67,510
+49,660
+278% +$865K 0.02% 960
2021
Q3 		$306K Sell
17,850
-17,570
-50% -$308K 0.01% 2022
2021
Q2 		$762K Sell
35,420
-19,833
-36% -$355K 0.01% 976
2021
Q1 		$830K Buy
55,253
+34,498
+166% +$558K 0.02% 924
2020
Q4 		$273K Sell
20,755
-12,024
-37% -$145K 0.01% 1149
2020
Q3 		$317K Buy
32,779
+6,780
+26% +$72.5K 0.01% 964
2020
Q2 		$297K Sell
25,999
-83,611
-76% -$947K 0.01% 888
2020
Q1 		$1.14M Buy
109,610
+20,812
+23% +$258K 0.1% 214
2019
Q4 		$1.46M Sell
88,798
-44,619
-33% -$675K 0.07% 395
2019
Q3 		$1.77M Buy
133,417
+476
+0.4% +$6.63K 0.06% 337
2019
Q2 		$1.87M Buy
132,941
+36,861
+38% +$587K 0.05% 351
2019
Q1 		$1.77M Buy
96,080
+37,348
+64% +$851K 0.07% 295
2018
Q4 		$1.53M Buy
58,732
+33,605
+134% +$790K 0.03% 264
2018
Q3 		$577K Sell
25,127
-65,564
-72% -$1.34M 0.01% 644
2018
Q2 		$1.73M Buy
90,691
+20,305
+29% +$340K 0.06% 284
2018
Q1 		$1.19M Buy
70,386
+51,214
+267% +$857K 0.04% 282
2017
Q4 		$291K Buy
19,172
+4,582
+31% +$68K 0.01% 814
2017
Q3 		$261K Sell
14,590
-15,221
-51% -$255K 0.01% 873
2017
Q2 		$486K Sell
29,811
-13,847
-32% -$200K 0.01% 579
2017
Q1 		$611K Sell
43,658
-6,889
-14% -$98.2K 0.02% 580
2016
Q4 		$806K Buy
50,547
+1,594
+3% +$25.6K 0.02% 473
2016
Q3 		$815K Buy
48,953
+36,234
+285% +$488K 0.02% 492
2016
Q2 		$142K Buy
+12,719
New +$123K ﹤0.01% 1475
2016
Q1 		– Sell
-43,204
Closed -$402K – 1987
2015
Q4 		$402K Buy
43,204
+2,428
+6% +$24.2K 0.01% 1037
2015
Q3 		$460K Buy
40,776
+19,582
+92% +$240K 0.02% 824
2015
Q2 		$269K Sell
21,194
-3,806
-15% -$41K 0.01% 1171
2015
Q1 		$232K Buy
+25,000
New +$282K 0.01% 1210

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's VNDA Position: Q1 2026 in Review

Tudor Investment Corp increased its Vanda Pharmaceuticals (VNDA) stake by 15% in Q1 2026, buying an estimated $105K and bringing the position to 102,255 shares worth $707K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.

Tudor Investment Corp first reported a position in VNDA in Q1 2015 and has held it in 39 quarters since. The position peaked at $1.87M in Q2 2019. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Tudor Investment Corp held 102,255 shares of Vanda Pharmaceuticals worth $707K as of Q1 2026.
  • Tudor Investment Corp bought 13,667 Vanda Pharmaceuticals shares in Q1 2026, an estimated $105K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2602 holding.
  • Tudor Investment Corp first reported a position in Vanda Pharmaceuticals in Q1 2015 and has held it in 39 quarters since.
  • Tudor Investment Corp's Vanda Pharmaceuticals position peaked at $1.87M in Q2 2019.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.